Real-world data of zanubrutinib treatment for patients with previously treated Waldenstrom Macroglobulinemia

被引：0
|
作者：
Jang, Seo Yoon [1 ]
Kwon, Soyean [1 ]
Byun, Ja Min [1 ]
Koh, Youngil [1 ]
Hong, Junshik [1 ]
Yoon, Sung-Soo [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-429
引用
收藏
页码：S277 / S277
页数：1
相关论文
共 50 条
  • [21] Fludarabine therapy in Waldenstrom's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine
    Lewandowski, K
    Halaburda, K
    Hellmann, A
    LEUKEMIA & LYMPHOMA, 2002, 43 (02) : 361 - 363
  • [22] Global Waldenstrom's Macroglobulinemia Patient-Derived Data Registry, Whimsical, Highlights Real-World Treatment Outcomes and COVID-19 Data
    Tohidi-Esfahani, Ibrahim
    Warden, Andrew
    Malunis, Elena
    Nardis, Peter Liburdide
    Postek, Michelle
    D'Sa, Shirley
    Kersten, Marie Jose
    Thomas, Sheeba K.
    Palomba, M. Lia
    Olszewski, Adam J.
    Guerin, Newton
    Scott, Clare
    Trotman, Judith
    BLOOD, 2021, 138
  • [23] Real-world treatment patterns, health care resource utilization (HRU), and costs among patients with Waldenstrom macroglobulinemia (WM) initiating therapy
    Schenkel, Brad
    Ellis, Lorie
    Korrer, Stephanie
    Byfield, Stacey DaCosta
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [24] Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer
    Acedo, Rocio Diaz
    Banqueri, Mercedes Galvan
    Criado, Silvia Artacho
    Parra, Eva Maria Fernandez
    Galan, Rocio Jimenez
    Sanchez, Ana Isabel Gago
    Pozo, Juan Francisco Marin
    Bautista, Maria Jose Martinez
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (02) : 382 - 389
  • [25] Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer
    Rocío Díaz Acedo
    Mercedes Galvan Banqueri
    Silvia Artacho Criado
    Eva María Fernández Parra
    Rocío Jiménez Galán
    Ana Isabel Gago Sánchez
    Juan Francisco Marín Pozo
    María José Martínez Bautista
    International Journal of Clinical Pharmacy, 2024, 46 : 382 - 389
  • [26] Real-world treatment patterns, adherence, costs, and healthcare resource utilization associated with Waldenstrom macroglobulinemia in the United States.
    Yang, Keri
    Castillo, Jorge J.
    Ratiu, Anna
    Delinger, Rachel
    Zimmerman, Todd
    Tang, Boxiong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Ixazomib, Dexamethasone and Rituximab in Previously Untreated Patients with Waldenstrom Macroglobulinemia
    Castillo, Jorge J.
    Gustine, Joshua
    Meid, Kirsten
    Dubeau, Toni
    Yang, Guang
    Xu, Lian
    Hunter, Zachary
    Treon, Steven P.
    BLOOD, 2016, 128 (22)
  • [28] Real-World Treatment Patterns, Survival, and Economic Burden Among Elderly MCL Patients Previously Treated With cBTKis
    Squires, Patrick
    Puckett, Justin
    Ryland, Katherine Elizabeth
    Kamal-Bahl, Sachin
    Raut, Monika
    Doshi, Jalpa
    Huntington, Scott F.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (10):
  • [29] Impact of Ibrutinib Dose Intensity on Patient Outcomes in Previously Treated Waldenstrom Macroglobulinemia
    Gustine, Joshua
    Meid, Kirsten
    Dubeau, Toni
    Severns, Patricia
    Treon, Steven P.
    Castillo, Jorge J.
    BLOOD, 2017, 130
  • [30] Activity of fludarabine in previously treated Waldenstrom's macroglobulinemia: A report of 71 cases
    Leblond, V
    Ben-Othman, T
    Deconinck, E
    Taksin, AL
    Harousseau, JL
    Delgado, MA
    Delmer, A
    Maloisel, F
    Mariette, X
    Morel, P
    Clauvel, JP
    Duboisset, P
    Entezam, S
    Hermine, O
    Merlet, M
    Yakoub-Agha, I
    Guibon, O
    Caspard, H
    Fort, N
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2060 - 2064
12345